Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare primary lymphedema characterized by bilateral, painless lower limb swelling present at birth. Prominent veins around the ankles and on the dorsa of the feet, dysplastic and upslanting toenails due to edema of the nailbed, and subtle dysmorphic facial features (such as high forehead, hypertelorism, depressed nasal bridge, mild bilateral ear dysplasia, and short neck) have also been described. The degree of lymphatic impairment is milder than in the otherwise clinically similar Milroy disease, as evidenced by slightly less severe lymphedema and significantly more uptake of tracers on lymphoscintigraphy.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for congenital primary lymphedema of Gordon.
1 publication has been identified in PubMed for congenital primary lymphedema of Gordon. Research spans Review / Meta-Analysis (100%).
Mimura T (2025). [PMID: 40459001](https://pubmed.ncbi.nlm.nih.gov/40459001/). *Cochrane Database Syst Rev*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:42 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning congenital primary lymphedema of Gordon
Updated May 26, 2026
A comprehensive analysis reveals significant histological and molecular alterations in primary lymphedema, providing insights into lymphatic reconstruction outcomes. This study enhances understanding of the disease's pathophysiology, which may inform future therapeutic strategies.